In summary, here we show that breast cancer cell-derived ANGPTL2 may play important roles in bone metastasis by enhancing responsiveness of breast cancer cells to bone tissue-secreted CXCL12 through up-regulated tumor cell CXCR4 expression. This evidence concerns the gene CXCL12 and breast carcinoma.